• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (COSTA RICA) INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT; PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (COSTA RICA) INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT; PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED Back to Search Results
Catalog Number TRM-360
Medical Device Problem Code Patient-Device Incompatibility (2682)
Health Effect - Clinical Codes Capsular Contracture (1761); Seroma (2069)
Date of Event 04/15/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
A review of the device history record has been completed.No deviations or non-conformances noted.The event of capsular contracture and seroma-late are physiological complications and analysis of the device generally does not assist allergan in determining a probable cause for these events.Reason for reoperation: "fluid around the implant", "swelling", "pain", looking "strange and shaped differently", suspicion of breast implant associated anaplastic large cell lymphoma (bia-alcl.) further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.This is a known potential adverse event addressed in the product labeling.
 
Event or Problem Description
Healthcare professional reported left-side capsular contracture, baker grade iii, "fluid around the implant", "swelling", "pain", looking "strange and shaped differently." device was explanted.
 
Additional Manufacturer Narrative
Device evaluation: visual analysis of the returned device identified: deformation, black particles, encapsulation and creases.Cloudy and bubbles after autoclave disinfection process in the gel.A weight test of the device was verified and the device was within specification.Based on the device analysis the final assessment is: no issues found related with the manufacturing.
 
Event or Problem Description
Healthcare professional reported left-side capsular contracture, baker grade iii, "fluid around the implant", "swelling", "pain", looking "strange and shaped differently." device was explanted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT
Common Device Name
PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED
Manufacturer (Section D)
ALLERGAN (COSTA RICA)
900 parkway global park
zona franca
CS 
MDR Report Key8714016
Report Number9617229-2019-07162
Device Sequence Number2663559
Product Code FTR
UDI-Device Identifier10888628008113
UDI-Public10888628008113
Combination Product (Y/N)N
Initial Reporter StateTX
PMA/510(K) Number
P020056
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2016
Device Explanted Year2019
Reporter Type Manufacturer
Report Source health professional
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 07/26/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date02/21/2021
Device Catalogue NumberTRM-360
Device Lot Number2887963
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/12/2019
Initial Date Received by Manufacturer 05/22/2019
Supplement Date Received by Manufacturer06/27/2019
Initial Report FDA Received Date06/19/2019
Supplement Report FDA Received Date07/26/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age62 YR
-
-